206 PRETARGET® RADIOIMMUNOTHERAPY (RIT) WITH A FUSION PROTEIN: PHARMACOKINETIC RESULTS FROM A DOSE OPTIMIZATION STUDY. (1st January 2004) - Forero-Torres, A; Shen, S; LoBuglio, A; Percent, I; Besch, S; Breitz, H; Sims, R; Meredith, R